Cargando…
Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889626/ https://www.ncbi.nlm.nih.gov/pubmed/35250889 http://dx.doi.org/10.3389/fendo.2022.840299 |
| _version_ | 1784661444726358016 |
|---|---|
| author | Lian, Jingxuan Fu, Jianfang |
| author_facet | Lian, Jingxuan Fu, Jianfang |
| author_sort | Lian, Jingxuan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8889626 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88896262022-03-03 Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis Lian, Jingxuan Fu, Jianfang Front Endocrinol (Lausanne) Endocrinology Frontiers Media S.A. 2022-02-16 /pmc/articles/PMC8889626/ /pubmed/35250889 http://dx.doi.org/10.3389/fendo.2022.840299 Text en Copyright © 2022 Lian and Fu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Endocrinology Lian, Jingxuan Fu, Jianfang Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis |
| title | Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis |
| title_full | Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis |
| title_fullStr | Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis |
| title_full_unstemmed | Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis |
| title_short | Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis |
| title_sort | corrigendum: pioglitazone for nafld patients with prediabetes or type 2 diabetes mellitus: a meta-analysis |
| topic | Endocrinology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889626/ https://www.ncbi.nlm.nih.gov/pubmed/35250889 http://dx.doi.org/10.3389/fendo.2022.840299 |
| work_keys_str_mv | AT lianjingxuan corrigendumpioglitazonefornafldpatientswithprediabetesortype2diabetesmellitusametaanalysis AT fujianfang corrigendumpioglitazonefornafldpatientswithprediabetesortype2diabetesmellitusametaanalysis |